Susquehanna International Group’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,591
Closed -$69.1K 13961
2025
Q4
$69.1K Sell
12,591
-4,446
-26% -$22.9K ﹤0.01% 11633
2025
Q3
$68K Buy
17,037
+14,129
+486% +$59.4K ﹤0.01% 11752
2025
Q2
$7.86K Buy
+2,908
New +$7.71K ﹤0.01% 12420
2024
Q4
Sell
-11,542
Closed -$108K 13053
2024
Q3
$108K Sell
11,542
-473
-4% -$4.56K ﹤0.01% 11010
2024
Q2
$129K Buy
12,015
+10,191
+559% +$138K ﹤0.01% 10839
2024
Q1
$27K Buy
1,824
+397
+28% +$5.53K ﹤0.01% 11748
2023
Q4
$27.3K Buy
+1,427
New +$34.9K ﹤0.01% 11900

Other funds holding RLYB

Susquehanna International Group's RLYB Position: Q1 2026 in Review

Susquehanna International Group sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 12,591 shares — an estimated $69.1K sold.

Susquehanna International Group first reported a position in RLYB in Q4 2023 and held it in 7 quarters. The position peaked at $129K in Q2 2024. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Susquehanna International Group reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 12,591 Rallybio shares in Q1 2026, an estimated $69.1K.
  • Susquehanna International Group first reported a position in Rallybio in Q4 2023 and held it in 7 quarters.
  • Susquehanna International Group's Rallybio position peaked at $129K in Q2 2024.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.